Home - Translational Cancer Research

New Impact Factor for Translational Cancer Research: 1.5

We are pleased to announce that Translational Cancer Research (TCR) has attained its latest impact factor update for the 2023 citation year: 1.5.

Translational Cancer Research 2023 CiteScore Released: 2.1

We are pleased to announce that the Translational Cancer Research (TCR) has received its 2023 CiteScore: 2.1, ranking 209 out of 333 journals in the Radiology, Nuclear Medicine and Imaging category.

Furthermore, we are delighted to highlight the remarkable achievements made by all AME journals in the CiteScore ranking.

Interviews with Outstanding Authors (2024)

In 2024, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors who have been making immense efforts in their research fields, with a brief interview of their unique perspectives and insightful views as authors.

Reviewer of the Month (2024)

In 2024, TCR reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

TCR 2023 Annual Report

Greetings from the Editorial Office of TCR!

We are pleased to share the 2023 Annual Report of Translational Cancer Research. 2023 has seen much progress for TCR. We hope 2023 will bring greater things to TCR. We would like to thank you for your support and assistance in improving the journal over the past year, and we certainly look forward to your innovations and contributions in 2024.

We would especially like to express our sincere gratitude to the editorial board members, guest editors, reviewers, authors, and readers for all your support and contributions to TCR. We wish you a happy, healthy and prosperous 2024!

Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases

Identification of differentially expressed genes. (A) Heatmap revealed differentially expressed genes; (B) univariate Cox regression analysis; (C) a protein-protein interaction network showing the relationship between ferroptosis-related genes and cuproptosis-related genes.

Bartholin’s gland carcinoma—the diagnostic and management challenges of a rare malignancy—a case report and review of current literature

FDG-avid right inguinal lymph node on axial CT-PET. The green arrow: FDG-avid right inguinal lymph node on axial CT-PET. FDG, fluorodeoxyglucose; CT-PET, computed tomography-positron-emission tomography.

Development of a novel angiogenesis-related lncRNA signature to predict the prognosis and immunotherapy of glioblastoma multiforme

Differences in risk scores for clinical characteristics. (A-D) The correlations between the risk score and sex, age, MGMT status, and IDH1 status were not significant (P>0.05). (E) Among the subtypes, the proneural subtypes had a significantly lower risk score than did the mesenchymal subtypes (P<0.05). **, P<0.01. IDH1, isocitrate dehydrogenase 1; MGMT, O6-methylguanine-DNA methyltransferase; ns, no significance.

Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma

Single-cell sequencing analysis of 20,074 cells from 7 ccRCC samples. (A) Pearson’s correlation between nFeature and nCount. (B) PCA plot colored by different samples. (C) Cells were classified into 25 clusters via UMAP algorithm. (D) Eight cell types were identified and annotated by marker genes. (E) Heatmap visualized top 5 marker genes among 8 cell clusters. (F) Visualization of gene expression in cell clusters. PC, principal component; UMAP, uniform manifold approximation and projection; NK, nature killer; ccRCC, clear cell renal cell carcinoma; PCA, principal component analysis.

Development and validation of nomograms to predict early death in non-small cell lung cancer patients with brain metastasis: a retrospective study in the SEER database

ROC curves for the nomograms of the all-cause early death and the cancer-specific early death in the training cohort (A,B) as well as in the validation cohort (C,D). ROC, receiver operating characteristic; AUC, area under the curve.

‹ ›

Vol 13, No 6 (June, 2024)

Articles in Press

Past Issues

About tcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: tcr@amepc.org
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Announcement more

New Impact Factor for Translational Cancer Research: 1.5

We are pleased to announce that Translational Cancer Research (TCR) has attained its latest impact factor update for the 2023 citation year: 1.5. More >>

Translational Cancer Research 2023 CiteScore Released: 2.1

We are pleased to announce that the Translational Cancer Research (TCR) has received its 2023 CiteScore: 2.1, ranking 209 out of 333 journals in the Radiology, Nuclear Medicine and... More >>

Join us at the 32nd Annual Meeting of the European Society of Thoracic Surgery

The 32nd Annual Meeting of the European Society of Thoracic Surgery is going to be held in May 26-28, 2024 in Barcelona, Spain: https://ests2024.com/ests2024. More >>

Original Article

Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancer

Ye Ji Jung, Joonghyun Ahn, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Sun Young Cho, Hyun Ae Jung

PDF Pages: 2587-2595 Full Text (94) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Extracellular vesicles isolated from curcumin-medium weakened RKO cell proliferation and migration

Chunyan Xu, Chengxia Liu

PDF Pages: 2596-2604 Full Text (73) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A novel inflammatory nutrient index for predicting survival outcomes in patients with non-small cell lung cancer

Tingtian Li, Qing Liu, Meng Li

PDF Pages: 2605-2617 Full Text (63) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Naringin inhibits cisplatin resistance of ovarian cancer cells by inhibiting autophagy mediated by the TGF-β2/smad2 pathway

Yi Wang, Yongsheng Wang, Chunying Yuan, Nanyi Wang, Tingsu Zhang

PDF Pages: 2618-2628 Full Text (66) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Construction and validation of a prognostic and therapeutic cuproptosis- and immune-related gene signature in hepatocellular carcinoma

Qianqian Cheng, Wei Wang, Zhenyu Lv, Wenbin Ji, Jing Liu, Xueli Zhou, Yan Yang

PDF Pages: 2629-2646 Full Text (72) Reporting Checklist Peer Review File COI Form Open Access

The prognostic value of immune escape-related genes in lung adenocarcinoma

Hao Ran Jia, Wen Chao Li, Lin Wu

PDF Pages: 2647-2661 Full Text (89) Reporting Checklist Peer Review File COI Form Open Access

Neoadjuvant therapy bridging percutaneous coronary intervention (PCI) and video-assisted thoracoscopic (VATS) lobectomy: a retrospective study

Lin Guo, Songlei Ou, Shaoyan Zhang, Dong Li, Xuchen Ma

PDF Pages: 2662-2673 Full Text (26) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Significance of dysregulated M2 macrophage and ESR2 in the ovarian metastasis of gastric cancer

Jianpeng Gao, Zhenxiong Zhao, Hongda Pan, Yakai Huang

PDF Pages: 2674-2690 Full Text (51) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Increase in GPIHBP1 expression in advanced stage colorectal cancer indicates poor immune surveillance

Min Gao, Liting Liao, Zhijie Lin, Xiangyu Hu, Linhui Jia, Weijuan Gong, Xiaoqin Jia

PDF Pages: 2691-2703 Full Text (39) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Construction of a new prognostic model for colorectal cancer based on bulk RNA-seq combined with The Cancer Genome Atlas data

Yu Ye, Gang Xu

PDF Pages: 2704-2720 Full Text (35) Reporting Checklist Peer Review File COI Form Open Access

Screening of postoperative adjuvant chemotherapy-related serum metabolic markers in breast cancer patients based on ¹H NMR metabonomics

Ranran Hou, Wenbin Huang, Yufeng Lin, Weiping Li, Jianwei Dong, Xinping Huang, Man Xu, Qian Li, Yongcheng Zhang, Yongxia Yang

PDF Pages: 2721-2734 Full Text (39) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for resectable esophageal cancer: a systematic review and meta-analysis

Mingxing Wang, Wanhui Dong, Aixin Liu, Tong Lai, Baorui Zhang, Qingming Sun

PDF Pages: 2735-2750 Full Text (41) Reporting Checklist Peer Review File COI Form Open Access

Development and external validation of a prognostic nomogram to predict survival in patients aged ≥60 years with pancreatic ductal adenocarcinoma

Binjiao Zheng, Gangfeng Ding, Guangrong Lu, Lili Li

PDF Pages: 2751-2766 Full Text (43) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

SYT7 promotes breast cancer cells growth through the PI3K/AKT pathway

Chenghao Luo, Qingfan Mo, Guosheng Ren

PDF Pages: 2767-2778 Full Text (37) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Head-to-head comparison of [⁶⁸Ga]Ga-FAPI-04 PET and [¹⁸F]FDG PET in the detection of cancer recurrence: a systematic review and meta-analysis

Qinchao Wu, Chen Wang, Chao Huang, Dan Li

PDF Pages: 2779-2789 Full Text (47) Reporting Checklist Peer Review File COI Form Open Access

Development of a prediction model for the association between thyroid dysfunction and breast cancer

Yuehong Tang, Bilin Zhu, Xuelian Wen, Yan Chen

PDF Pages: 2790-2798 Full Text (55) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma

Haoran Wang, Xian Shui, Zheng Zhang, Meng He, Sheng Tai, Yujia Lin

PDF Pages: 2799-2811 Full Text (75) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Overexpression of CENPU promotes cancer growth and metastasis and is associated with poor survival in patients with nasopharyngeal carcinoma

Cheng Lin, Jiani Xiong, Yuebing Chen, Huiping Zheng, Meifang Li

PDF Pages: 2812-2824 Full Text (54) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Prognostic value of GARS in bladder cancer and its role in the tumor microenvironment

Kaifei Chen, Shuaiqi Chen, Shangrong Wu, Guangyu Sun, Yuchen Jiang, Ranlu Liu

PDF Pages: 2825-2846 Full Text (53) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

MFAP2 induces epithelial-mesenchymal transformation of osteosarcoma cells by activating the Notch1 pathway

Shan Jiang, Ziang Zheng, Bo Yuan, Rushan Yan, Qijun Yao, Haoran Chen, Yongxun Zhang, Yue Lei, Haidong Liang

PDF Pages: 2847-2859 Full Text (51) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Identification of tumor antigens for mRNA vaccines and ferroptosis-related landscape in esophageal squamous cell carcinoma

Qin Zeng, Bo Chen, Wei Wang

PDF Pages: 2860-2876 Full Text (50) Reporting Checklist Peer Review File COI Form Open Access

Value analysis of ITLN1 in the diagnostic and prognostic assessment of colorectal cancer

Yun Zhang, Tianyuan Gao, Min Wu, Zhengyuan Xu, Huixian Hu

PDF Pages: 2877-2891 Full Text (64) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Analysis of methylation-driven genes for predicting the prognosis of patients with oral squamous cell carcinoma

Jun Chen, Zejun Dong, Biaodong Li, Zhiliang Nie, Jiaxuan Qiu

PDF Pages: 2892-2904 Full Text (48) Reporting Checklist Peer Review File COI Form Open Access

The risk and survival of multiple myeloma as the second primary malignancy in a single Chinese center

Xiaoli Zhao, Jiamei Ji, Yating Li, Yunqi Cui, Zhengxu Sun, Xiaoyan Qu

PDF Pages: 2905-2912 Full Text (33) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma

Yuwei Yao, Qi Zhang, Sitian Wei, Haojia Li, Ting Zhou, Qian Zhang, Jiarui Zhang, Jun Zhang, Hongbo Wang

PDF Pages: 2913-2937 Full Text (54) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A signature of four ferroptosis-related genes in laryngeal squamous cell carcinoma

Runyu Zhao, Qun Chen, Peipei Qiao, Yingying Lu, Xiaoping Chen

PDF Pages: 2938-2949 Full Text (36) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Status and development of research on clear cell carcinoma of the ovary—a visualization-based bibliometric analysis

Chao Chen, Wei Ren, Lipeng Pei, Jingli Sun, Tianmei Bai

PDF Pages: 2950-2970 Full Text (48) Peer Review File COI Form Open Access

Clinicopathological significance of cancer stem cell marker CD44/SOX2 in esophageal squamous cell carcinoma (ESCC) patients and construction of a nomogram to predict overall survival

Siyue Tian, Ruibin Ma, Yingmin Liu, Fei Chen, Xiaotong Huang, Qianqian Yang, Wei Nian, Zhiqin Fan

PDF Pages: 2971-2984 Full Text (37) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Bioinformatics prediction and experimental verification identify a cuproptosis-related gene signature as prognosis biomarkers of hepatocellular carcinoma

Weiwei Wang, Zhiguo He, Haowen Jia, Jiansheng Zhang, Feng Qi

PDF Pages: 2985-3002 Full Text (59) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Benefits of adjuvant chemotherapy in elderly patients with stage IB–IIIB non-small cell lung cancer: a propensity-matched analysis

Xuan Qin, Xiangzhi Xiao, Hongwei Xia, Ke Yang, Shengchao Zhang

PDF Pages: 3003-3015 Full Text (43) Reporting Checklist Peer Review File COI Form Open Access

Retrospective clinical study analysis of skin adverse reactions related to epidermal growth factor receptor inhibitors

Jin-Ming Qu, Si-Jian Wen, You-Kun Lin, Hua-Xiang Lu, Kun-Qian Huang, Christoffer T. Maansson, Chung-Shien Lee, Taisuke Araki

PDF Pages: 3016-3030 Full Text (44) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death

Xiongjie Zhu, Wenkai Zhang, Zhongjian Yu, Xia Yang, Laiqing Li, Cuicui Chen, Temirbek Djumanazarov, David Piquemal, Abrorjon A. Yusupbekov, Yanfang Zheng

PDF Pages: 3031-3045 Full Text (50) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma

Rui Huang, Hongchun Liu, Changmin Wang

PDF Pages: 3046-3061 Full Text (45) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

ITGAM sustains MAPK signaling and serves as an adverse prognostic factor and therapeutic target in acute myeloid leukemia

Chang Zhou, Lu Yang, Kai Zhao, Libo Jiang

PDF Pages: 3062-3074 Full Text (54) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Combining non-invasive liquid biopsy and a methylation analysis to assess surgical risk for early esophageal cancer

Xiaole Chen, Mingyan Li, Yongliang Li, Alberto Aiolfi, Luigi Bonavina, Toni Lerut, Xiuxia Wu, Qinsheng Zhang

PDF Pages: 3075-3089 Full Text (44) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Review Article

Exosomal microRNAs in lung cancer: a narrative review

Zhe Zhang, Fengwu Lin, Wenqi Wu, Jingyuan Jiang, Chen Zhang, Dongliang Qin, Zhenan Xu

PDF Pages: 3090-3105 Full Text (24) Reporting Checklist Peer Review File COI Form Open Access

Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells

Zheng Dou, Xiao-Ting Ma, Mei-Na Piao, Jian-Ping Wang, Jin-Li Li

PDF Pages: 3106-3125 Full Text (53) Peer Review File COI Form Open Access

Ferroptosis: a promising target for fumarate hydratase-deficient tumor therapeutics literature review

Ping Cheng, Ruohan Xia, Xianwang Wang

PDF Pages: 3126-3141 Full Text (56) Reporting Checklist Peer Review File COI Form Open Access

Involvement of long non-coding RNA LOXL1-AS1 in the tumourigenesis and development of malignant tumours: a narrative review

Xinmeng Wang, Ruai Liu, Jinsong Li, Boyong Wang, Yaru Lin, Jiaji Zi, Min Yu, Yuanqian Pu, Wei Xiong

PDF Pages: 3142-3155 Full Text (21) Reporting Checklist Peer Review File COI Form Open Access

Mechanisms and therapeutic targets of ErbB family receptors in hepatocellular carcinoma: a narrative review

Zeyuan Qiang, Juan Wan, Xiangzheng Chen, Haichuan Wang

PDF Pages: 3156-3178 Full Text (44) Reporting Checklist Peer Review File COI Form Open Access

Letter to the Editor

Predicting papillary thyroid microcarcinoma in TI-RADS 3 nodules: a combined radiomics and clinical model

Zhe Hu, Zhikang Tian, Xi Wei, Yueqin Chen

PDF Pages: 3179-3180 Full Text (33) COI Form Open Access

Retraction

Retraction: inhibitory effect of lovastatin on human lung cancer cell proliferation by regulating the ERK1/2 and COX-2 pathways

Sha Liu, Ping Yang, Mingkung Wang, Shuang Zhang, Jie Wang, Tao Pan, Ping Zhou

PDF Pages: 3181 Full Text (40) COI Form Open Access

Original Article

Effect of fasting therapy in chemotherapy-protection and tumorsuppression: a systematic review

Lei Sun, Yong-Jiang Li, Xi Yang, Ling Gao, Cheng Yi

Review Article

The management of brain necrosis as a result of SRS treatment for intra-cranial tumors

Uresh Patel, Ankush Patel, Charles Cobb, Tara Benkers, Sandra Vermeulen

Common applications of next-generation sequencing technologies in genomic research

Chien-Yueh Lee, Yu-Chiao Chiu, Liang-Bo Wang, Yu-Lun Kuo, Eric Y. Chuang, Liang-Chuan Lai, Mong-Hsun Tsai

Magnetic resonance imaging of pancreatic malignancy

Mellena D. Bridges

EGFR and HER2: is there a role in ovarian cancer?

Eleonora Teplinsky, Franco Muggia

Advances on immunotherapy in breast cancer

Kanthi Athreya, Sonia Ali

Targeting the folate receptor for the treatment of ovarian cancer

Robert J. Lutz

Computational resources for radiomics

Laurence E. Court, Xenia Fave, Dennis Mackin, Joonsang Lee, Jinzhong Yang, Lifei Zhang

Editorial

Morphine, when used for treating patients with acute pancreatitis, could be more risky than previously suspected

Juan Iovanna, Maria Cecilia Mallmann

The CROSS road in neoadjuvant therapy for esophageal cancer: long-term results of CROSS trial

Ian Wong, Simon Law

Immunotherapy in endometrial cancer: who are the most appropriate patients?

Katherine C. Kurnit, Amir A. Jazaeri

Meta-Analysis

Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: a meta-analysis

Ping Zhan, Qian Qian, Benjamin Wan, Tristan D. Yan, Li-Ke Yu

Review Articles

Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer

Deep Kwatra, Anand Venugopal, Shrikant Anant

Alternative pathways of non-homologous end joining (NHEJ) in genomic instability and cancer

Rositsa Dueva, George Iliakis

Mini-Review

The emerging role of chemokine receptor CXCR2 in cancer progression

Tanweer Jaffer, Daqing Ma

Original Article

Impact of image preprocessing on the volume dependence and prognostic potential of radiomics features in non-small cell lung cancer

Xenia Fave, Lifei Zhang, Jinzhong Yang, Dennis Mackin, Peter Balter, Daniel Gomez, David Followill, A. Kyle Jones, Francesco Stingo, Laurence E. Court

Review Article

Cancer biomarker discovery and validation

Nicolas Goossens, Shigeki Nakagawa, Xiaochen Sun, Yujin Hoshida

Liquid biopsy for cancer screening, patient stratification and monitoring

Graham Brock, Elena Castellanos-Rizaldos, Lan Hu, Christine Coticchia, Johan Skog

Prostate cancer radiomics and the promise of radiogenomics

Radka Stoyanova, Mandeep Takhar, Yohann Tschudi, John C. Ford, Gabriel Solórzano, Nicholas Erho, Yoganand Balagurunathan, Sanoj Punnen, Elai Davicioni, Robert J. Gillies, Alan Pollack

Review Articles

DNA double strand break repair via non-homologous end-joining

Anthony J. Davis, David J. Chen

Nanoparticles in radiation therapy: a summary of various approaches to enhance radiosensitization in cancer

Deep Kwatra, Anand Venugopal, Shrikant Anant

DNA damage tolerance: a double-edged sword guarding the genome

Gargi Ghosal, Junjie Chen

Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment

Feng-Ming Hsu, Shichuan Zhang, Benjamin P.C. Chen

Normal tissue protection for improving radiotherapy: where are the Gaps?

Pataje G.S. Prasanna, Helen B. Stone, Rosemary S. Wong, Jacek Capala, Eric J. Bernhard, Bhadrasain Vikram, C. N. Coleman

MDM2 and MDMX: alone and together in regulation of p53

Miriam Shadfan, Vanessa Lopez-Pajares, Zhi-Min Yuan

Tumor microenvironment and nanotherapeutics

Meenakshi Upreti, Amar Jyoti, Pallavi Sethi

SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis

Seong-Hoon Park, Yuming Zhu, Ozkan Ozden, Hyun-Seok Kim, Haiyan Jiang, Chu-Xia Deng, David Gius, Athanassios Vassilopoulos

Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization

Jay F. Dorsey, Lova Sun, Daniel Y. Joh, Alon Witztum, Ajlan Al Zaki, Gary D. Kao, Michelle Alonso-Basanta, Stephen Avery, Andrew Tsourkas, Stephen M. Hahn

DNA crosslinking damage and cancer - a tale of friend and foe

Yaling Huang, Lei Li

Alternative pathways of non-homologous end joining (NHEJ) in genomic instability and cancer

Rositsa Dueva, George Iliakis

Radiosensitization by gold nanoparticles: effective at megavoltage energies and potential role of oxidative stress

Karl T. Butterworth, Stephen J. McMahon, Laura E. Taggart, Kevin M. Prise

Role of p53 in regulating tissue response to radiation by mechanisms independent of apoptosis

Chang-Lung Lee, Jordan M. Blum, David G. Kirsch

Intestinal stem cell injury and protection during cancer therapy

Jian Yu

Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury

Lijian Shao, Yingying Wang, Jianhui Chang, Yi Luo, Aimin Meng, Daohong Zhou

Biological basis of IORT

Immune effects of high dose radiation treatment: implications of ionizing radiation on the development of bystander and abscopal effects

Ithaisa Sologuren, Carlos Rodríguez-Gallego, Pedro Carlos Lara

Original Article

A recursively partitioned mixture model for clustering time-course gene expression data

Devin C. Koestler, Carmen J. Marsit, Brock C. Christensen, Karl T. Kelsey, E. Andres Houseman

Statistical strategies for microRNAseq batch effect reduction

Yan Guo, Shilin Zhao, Pei-Fang Su, Chung-I Li, Fei Ye, Charles R. Flynn, Yu Shyr

Defining functional changes in the brain caused by targeted stereotaxic radiosurgery

Vipan K. Parihar, Munjal M. Acharya, Dante E. Roa, Omar Bosch, Lori-Ann Christie, Charles L. Limoli

A chain reaction approach to modelling gene pathways

Gary C. Cheng, Dung-Tsa Chen, James J. Chen, Seng-jaw Soong, Coral Lamartiniere, Stephen Barnes

Oncolytic virus-mediated tumor radiosensitization in mice through DNA-PKcs-specific shRNA

Takashi Kon, Xiuwu Zhang, Qian Huang, Zhonghui Yang, Shanling Liu, Bin Yan, Fang Li, He Wang, Chuan-Yuan Li

Identification of cancer mechanisms through computational systems modeling

Zhen Qi, Eberhard O. Voit

Frameless single-isocenter intensity modulated stereotactic radiosurgery for simultaneous treatment of multiple intracranial metastases

Steven K. M. Lau, Xiao Zhao, Ruben Carmona, Erik Knipprath, Daniel R. Simpson, Sameer K. Nath, Gwe-Ya Kim, Jona A. Hattangadi, Clark C. Chen, Kevin T. Murphy

Matrix metalloproteinase (MMP) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (HNSCC) cell lines

Amber M. Bates, Maria Paula Gomez Hernandez, Emily A. Lanzel, Fang Qian, Kim A. Brogden

Coexpression and expression quantitative trait loci analyses of the angiogenesis gene-gene interaction network in prostate cancer

Hui-Yi Lin, Chia-Ho Cheng, Dung-Tsa Chen, Y. Ann Chen, Jong Y. Park

How are lung cancer risk perceptions and cigarette smoking related?—testing an accuracy hypothesis

Lei-Shih Chen, Kimberly A. Kaphingst, Tung-Sung Tseng, Shixi Zhao

Alcohol intake patterns for cancer and non-cancer individuals: a population study

Hui-Yi Lin, Paige Fisher, Darian Harris, Tung-Sung Tseng

Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial

Dung-Tsa Chen, Michael J. Schell, William J. Fulp, Fredrik Pettersson, Sungjune Kim, Jhanelle E. Gray, Eric B. Haura

Review Article

Integrative clustering methods for high-dimensional molecular data

Prabhakar Chalise, Devin C. Koestler, Milan Bimali, Qing Yu, Brooke L. Fridley

Sparse principal component analysis in cancer research

Ying-Lin Hsu, Po-Yu Huang, Dung-Tsa Chen

An improved understanding of cancer genomics through massively parallel sequencing

Jamie K. Teer

Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications

Louis Dubeau

Cancer biomarker discovery and validation

Nicolas Goossens, Shigeki Nakagawa, Xiaochen Sun, Yujin Hoshida

The promise and challenge of ovarian cancer models

Noor Hasan, Anders W. Ohman, Daniela M. Dinulescu

Prostate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management

Howard B. Lieberman, Alex J. Rai, Richard A. Friedman, Kevin M. Hopkins, Constantinos G. Broustas

Exosomal lncRNAs as new players in cell-to-cell communication

Mihnea Dragomir, Baoqing Chen, George A. Calin

Repurposing DNA repair factors to eradicate tumor cells upon radiotherapy

Souparno Bhattacharya, Aroumougame Asaithamby

Translational research in radiation-induced DNA damage signaling and repair

Jac A. Nickoloff, Mary-Keara Boss, Christopher P. Allen, Susan M. LaRue

Genetically engineered mouse models for studying radiation biology

Katherine D. Castle, Mark Chen, Amy J. Wisdom, David G. Kirsch

Renal cell carcinoma: the search for a reliable biomarker

Nicholas J. Farber, Christopher J. Kim, Parth K. Modi, Jane D. Hon, Evita T. Sadimin, Eric A. Singer

Advances on immunotherapy in genitourinary and renal cell carcinoma

Gregory P. Botta, Eric Granowicz, Carrie Costantini

The role of novel immunotherapies in non-Hodgkin lymphoma

Allyson Pishko, Sunita D. Nasta

MDMX under stress: the MDMX-MDM2 complex as stress signals hub

Anna de Polo, Varunika Vivekanandan, John B. Little, Zhi-Min Yuan

Do p53 stress responses impact organismal aging?

Paul Hasty, Judith Campisi, Z. Dave Sharp

Pharmacological targeting of mutant p53

Samuel Kogan, Darren Carpizo

Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis

Michael I. Carr, Stephen N. Jones

Regulation of cytotoxic T-cell responses by p53 in cancer

Mitchell W. Braun, Tomoo Iwakuma

The IGF-1R/AKT pathway determines cell fate in response to p53

Lei Duan, Carl G. Maki

Intra molecular interactions in the regulation of p53 pathway

Jiandong Chen

TP53 mutations in epithelial ovarian cancer

Yu Zhang, Lan Cao, Daniel Nguyen, Hua Lu

Modulation of the p53 family network by RNA-binding proteins

Chris Lucchesi, Jin Zhang, Xinbin Chen

Radiomics in head and neck cancer: from exploration to application

Andrew J. Wong, Aasheesh Kanwar, Abdallah S. Mohamed, Clifton D. Fuller

Prostate cancer radiomics and the promise of radiogenomics

Radka Stoyanova, Mandeep Takhar, Yohann Tschudi, John C. Ford, Gabriel Solórzano, Nicholas Erho, Yoganand Balagurunathan, Sanoj Punnen, Elai Davicioni, Robert J. Gillies, Alan Pollack

Positron emission tomography/computerized tomography for tumor response assessment—a review of clinical practices and radiomics studies

Wei Lu, Wengen Chen

The emerging field of radiomics in esophageal cancer: current evidence and future potential

Peter SN. van Rossum, Cai Xu, David V. Fried, Lucas Goense, Laurence E. Court, Steven H. Lin

Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat’s in the fire

Jung H. Suh, Julie D. Saba

Computational methods and opportunities for phosphorylation network medicine

Yian Ann Chen, Steven A. Eschrich

Editorial

Focusing in on radiation induced brain injury

M. Kerry O’Banion

Targeting HSP90 in malignant gliomas: onalespib as a potential therapeutic

Naomi Lomeli, Daniela A. Bota

Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma

David C. Binder, Erik Ladomersky, Alicia Lenzen, Lijie Zhai, Kristen L. Lauing, Sebastian D. Otto-Meyer, Rimas V. Lukas, Derek A. Wainwright

New light on the pancreatic cyst conundrum

Nathan A. Berger

HNF1A, KRT81, and CYP3A5: three more straws on the back of pancreatic cancer?

Andrew J. Scott, John C. Wilkinson

Bevacizumab as an adjuvant therapy for glioblastoma in elderly patients: the facts

Kristopher A. Lyon, Jason H. Huang

Disulfiram combats cancer via crippling valosin-containing protein/p97 segregase adaptor NPL4

Nan Ding, Qianzheng Zhu

Hypofractionated whole breast irradiation is cost-effective—but is that enough to change practice?

Apar Gupta, Nisha Ohri, Bruce G. Haffty

Cost-effectiveness in managing skeletal related events in breast cancer: a strategy of less-intense dosing schedule of bone modifying agents

Sri Harsha Tella, Anuhya Kommalapati, Ryan K. Singhi

CRISPR-based genetic interaction maps inform therapeutic strategies in cancer

Poornima Ramkumar, Martin Kampmann

Smooth sailing for immunotherapy for unresectable stage III nonsmall cell lung cancer: the PACIFIC study

Melin J. Khandekar, Rakesh Jain

The evolving role of molecular profiling in prostate cancer: basal and luminal subtyping transcends tissue of origin

Omar Y. Mian, Rahul D. Tendulkar, Mohamed E. Abazeed

Serrated polyposis: the problem of definition and its relationship to the population at risk for syndrome-related colorectal cancer

Joanne P. Young, Timothy J. Price, Susan Parry

Multifactorial regulators of tumor programmed death-ligand 1 (PD-L1) response

R. Dixon Dorand, Agne Petrosiute, Alex Y. Huang

Therapeutic targeting of oncogenic KRAS in pancreatic cancer by engineered exosomes

Theresa L. Whiteside

TIC10/ONC201—a potential therapeutic in glioblastoma

Georg Karpel-Massler, Markus D. Siegelin

IDH mutational status and the immune system in gliomas: a tale of two tumors?

Bryan D. Choi, William T. Curry

ONC201: a new treatment option being tested clinically for recurrent glioblastoma

Marie D. Ralff, Amriti R. Lulla, Jessica Wagner, Wafik S. El-Deiry

When better still might not be good enough

Waldemar Debinski

Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapy

Vincent C. O. Njar

Co-inhibitory receptor programmed cell death protein 1 targets co-stimulatory CD28

Leonardo Chicaybam, Prasad S. Adusumilli

Exosome mediated phenotypic changes in lung cancer pathophysiology

Yoshihisa Shimada, John D. Minna

Signatures of field cancerization: a step towards earlier detection of esophageal adenocarcinoma

Aaron D. DeWard, Rebecca J. Critchley-Thorne

From tumorigenesis to microenvironment and immunoregulation: the many faces of focal adhesion kinase and challenges associated with targeting this elusive protein

Felicia L. Lenzo, William G. Cance

New incriminating evidence against IGF2

Wen Ding, Lina A. Shehadeh

Targeting cancer with tumor-specific therapeutic strategies—metabolic reprogramming beyond the Warburg effect

Paul Grippo, Ajay V. Maker

Branched chain amino acid metabolism and cancer: the importance of keeping things in context

Elizabeth M. Selwan, Aimee L. Edinger

RIPK1-TRAF2 interplay on the TNF/NF-κB signaling, cell death, and cancer development in the liver

Satomi Yamamoto, Tomoo Iwakuma

Genome-based modeling for adjusting radiotherapy dose (GARD)-a significant step toward the future of personalized radiation therapy

Michael J. Baine, Chi Lin

Rogue one: another faction of the Wnt empire implicated in assisting GBM progression

Riasat Ahsan, Shivani Baisiwala, Atique U. Ahmed

Normalizing tumoral vessels to treat cancer: an out-of-the-box strategy involving TIE2 pathway

Juan Fueyo, Mohammad B. Hossain, Teresa Nguyen, Candelaria Gomez-Manzano

Exploring gold nanoparticle interactions with proteins and the tumor microenvironment in biological systems

Li Tian, Ashley Chang, Marites P. Melancon

IL-6, cancer and cachexia: metabolic dysfunction creates the perfect storm

James P. White

Low-frequency ultrasound may improve drug penetration in colonic mucosa

Qiubing Chen, Bo Xiao, Didier Merlin

Dividing and conquering the variation among variants in EML4-ALK lung cancer

Trever G. Bivona

Unlocking the epigenetic code of T cell exhaustion

Jiazhu Wu, Huidong Shi

KDM1 links nuclear GSK3β to epigenetic alterations

Weijie Guo, Binhua P. Zhou

Moving the mountain in advanced non-small-cell lung cancer: evolving immunotherapies for a dire disease

Deepa Rangachari, Daniel B. Costa

Taming immune suppressor: application of myeloid-derived suppressor cells in anti-cancer gene therapy

Bhagelu R. Achyut, Ali S. Arbab

Neuroendocrine differentiation in prostate cancer: key epigenetic players

Karishma Gupta, Sanjay Gupta

PD-L1 is a diverse molecule regulating both tumor-intrinsic signaling and adaptive immunosuppression

Kim A. Brogden, Shireen Vali, Taher Abbasi

Mesenchymal stromal cells and interferon α (IFNα) in cancer immunotherapy

Diana Saleiro, Sara G. Radecki, Leonidas C. Platanias

The potential role of curcumin in prostate cancer: the importance of optimizing pharmacokinetics in clinical studies

Keith T. Schmidt, William D. Figg

Information-dense analysis for information-dense understanding

Nikola A. Ivica, Mandeep Kaur, Guangan Hu, Jianzhu Chen

The “liquid biopsy” in non-small cell lung cancer—not quite ready for prime time use

Angel Qin, Nithya Ramnath

Immune infiltration, glioma stratification, and therapeutic implications

Manny D. Bacolod, Sarmistha Talukdar, Luni Emdad, Swadesh K. Das, Devanand Sarkar, Xiang-Yang Wang, Francis Barany, Paul B. Fisher

Balancing redox stress: anchorage-independent growth requires reductive carboxylation

Clint.A Stalnecker, Ahmad.A Cluntun, Richard.A Cerione

Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy

Fabiana Perna, Michel Sadelain

Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cells

Alex J. Gooding, William P. Schiemann

Actionable intelligence provided by pancreatic cancer genomic landscape: are targets for curative therapy on the map?

Nathan A. Berger

Microtubule targeting agents in glioma

Anda-Alexandra Calinescu, Maria G. Castro

Moving molecular subtypes to the clinic in gastric cancer

Joseph Chao, Jeeyun Lee, Samuel J. Klempner

Intraoperative subtyping of lung adenocarcinoma: an unmet need

Nurlan Aliyev, Yusuke Takahashi, Shaohua Lu, Marissa Mayor, Prasad S. Adusumilli

Emerging roles of FGF signaling in hepatocellular carcinoma

Nana Zheng, Wenyi Wei, Zhiwei Wang

Tregs, Helios and tumor immunity: the sun has not yet risen

Angela M. Thornton, Ethan M. Shevach

Immune checkpoint regulator: a new assignment proposed for the classic adhesion molecule P-selectin glycoprotein ligand-1

Jiaxuan Chen, Carolyn A. Haller, Elliot L. Chaikof

Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components

Brandon J. Manley, James J. Hsieh

Multimodal action of ONECUT2 in driving neuroendocrine prostate cancer

Salma Kaochar, Nicholas Mitsiades

Letter to the Editor

Epigenetic regulation of PD-L1 expression and pancreatic cancer response to checkpoint immunotherapy

Chunwan Lu, Kebin Liu

Synthetic lethality vs. synthetic viability due to PARP1 and BRCA2 loss

Xia Ding, Shyam K. Sharan

Correspondence

Targeted attack: mechanisms by which ovarian cancers suppress the immune system

Irina V. Tiper, Tonya J. Webb

Brief Report

The impact of neighborhood disadvantage on health-related quality of life among African American and white cancer survivors

Chien-Ching Li, Alicia K. Matthews, Anjali Asthana, Raj C. Shah

Research Highlight

Butyrate consumption of differentiated colonocytes in the upper crypt promotes homeostatic proliferation of stem and progenitor cells near the crypt base

Scott J. Bultman

Commentary

Molecular heterogeneity of localized prostate cancer: more different than alike

Jeffrey J. Tosoian, Emmanuel S. Antonarakis

A crowded, but still varied, space: brigatinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer

Sawsan Rashdan, David E. Gerber

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer

Scott T. Eblen, Amber Bradley

Exportin 1/chromosome region maintenance 1 as a therapeutic target for lung cancer

Weimin Gao

The role of tumor-derived exosomes in epithelial mesenchymal transition (EMT)

Theresa L. Whiteside

[¹⁸F]-choline PET/CT as an imaging biomarker for primary liver cancers

Zhenghong Lee

Empiric H. pylori therapy—10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best

Yoshio Yamaoka, David Y. Graham

JAK3-mediated phosphorylation of EZH2: a novel mechanism of non-canonical EZH2 activation and oncogenic function

Theodoros Karantanos, Vassiliki A. Boussiotis

Cisplatin, etoposide, and irinotecan for relapsed small-cell lung cancer

Angel Qin, Gregory P. Kalemkerian

Helicobacter pylori vacuolating cytotoxin and gastric cancer risk: reconsidered

Muhammad Miftahussurur, Yoshio Yamaoka, David Y. Graham

Colonic crypts are natural gatekeepers of microbial metabolites to protect stem cells

Praveen Kumar Vemula, Venkatakrishna Rao Jala

Helios—controller of Treg stability and function

Claire Chougnet, David Hildeman

Directing abiraterone metabolism: balancing the scales between clinical relevance and experimental observation

Jon K. Obst, Marianne D. Sadar

Novel insights into the oncogenic function of the SMYD3 lysine methyltransferase

Pawel K. Mazur, Or Gozani, Julien Sage, Nicolas Reynoird

Fat lure: adipocytes attract cancer cells out of the prostate

Alexandra M. Blee, Haojie Huang

Impact of genomic heterogeneity associated with acquired anti-EGFR resistance in colorectal cancers

Guoli Chen, Ming-Tseh Lin

Editorials

Into the eye of the storm: breast cancer’s somatic mutation landscape points to DNA damage and repair

Joanne Ngeow, Emily Nizialek, Charis Eng

Perspective

Circular RNAs and competing endogenous RNA (ceRNA) networks

Apratim Mitra, Karl Pfeifer, Ki-Sun Park

The STAMPEDE trial: paradigm-changing data through innovative trial design

Bradley C. Carthon, Emmanuel S. Antonarakis

Regulation of chemo-sensitivity in ovarian cancer via a stroma dependent glutathione pathway

Derek B. Oien, Jeremy Chien, Nikki Cheng

Feed your gut with caution!

Vishal Singh, Beng San Yeoh, Matam Vijay-Kumar

Precision oncology: identifying predictive biomarkers for the treatment of metastatic renal cell carcinoma

Parth K. Modi, Nicholas J. Farber, Eric A. Singer

Letter to the Editors

Multiscale modeling of glioblastoma

Huaming Yan, Mónica Romero-López, Lesly I. Benitez, Kaijun Di, Hermann B. Frieboes, Christopher C. W. Hughes, Daniela A. Bota, John S. Lowengrub

Research Highlights

A balancing act for breast cancer? Everolimus for hormone receptor positive patients

Stephanie B Wheeler, Katherine Reeder-Hayes, Anne-Marie Meyer

Review Articles

New developments in treatment planning and verification of particle beam therapy

Reinhard W. Schulte, Andrew J. Wroe

Externally modulated theranostic nanoparticles

Cordula Urban, Alexander S. Urban, Heather Charron, Amit Joshi

Intestinal stem cell injury and protection during cancer therapy

Jian Yu

Cancer stem cells in glioma: challenges and opportunities

Jialiang Wang, Yufang Ma, Michael K. Cooper

Tumor microenvironment and nanotherapeutics

Meenakshi Upreti, Amar Jyoti, Pallavi Sethi

Hematopoietic stem cell senescence and cancer therapy-induced long-term bone marrow injury

Lijian Shao, Yingying Wang, Jianhui Chang, Yi Luo, Aimin Meng, Daohong Zhou

Role of p53 in regulating tissue response to radiation by mechanisms independent of apoptosis

Chang-Lung Lee, Jordan M. Blum, David G. Kirsch

DNA ligases as therapeutic targets

Alan E. Tomkinson, Timothy R.L. Howes, Nathaniel E. Wiest

DNA damage tolerance: a double-edged sword guarding the genome

Gargi Ghosal, Junjie Chen

DNA double strand break repair via non-homologous end-joining

Anthony J. Davis, David J. Chen

DNA crosslinking damage and cancer - a tale of friend and foe

Yaling Huang, Lei Li

Convergence of nanotechnology with radiation therapy—insights and implications for clinical translation

Dev Kumar Chatterjee, Tatiana Wolfe, Jihyoun Lee, Aaron P Brown, Pankaj Kumar Singh, Shanta Raj Bhattarai, Parmeswaran Diagaradjane, Sunil Krishnan

MDM2 and MDMX: alone and together in regulation of p53

Miriam Shadfan, Vanessa Lopez-Pajares, Zhi-Min Yuan

Sensitization of tumor cells to cancer therapy by molecularly targeted inhibition of the inhibitor of nuclear factor κB kinase

Lijian Shao, Lixian Wu, Daohong Zhou

Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment

Feng-Ming Hsu, Shichuan Zhang, Benjamin P.C. Chen

SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis

Seong-Hoon Park, Yuming Zhu, Ozkan Ozden, Hyun-Seok Kim, Haiyan Jiang, Chu-Xia Deng, David Gius, Athanassios Vassilopoulos

Normal tissue protection for improving radiotherapy: where are the Gaps?

Pataje G.S. Prasanna, Helen B. Stone, Rosemary S. Wong, Jacek Capala, Eric J. Bernhard, Bhadrasain Vikram, C. N. Coleman

Improving chemoradiotherapy with nanoparticle therapeutics

Michael Joseph Eblan, Andrew Zhuang Wang

Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization

Jay F. Dorsey, Lova Sun, Daniel Y. Joh, Alon Witztum, Ajlan Al Zaki, Gary D. Kao, Michelle Alonso-Basanta, Stephen Avery, Andrew Tsourkas, Stephen M. Hahn

Molecular mechanisms involved in tumor repopulation after radiotherapy

Wooi-Loon Ng, Qian Huang, Xinjian Liu, Mary Zimmerman, Fang Li, Chuan-Yuan Li

Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules

Julio A. Gutierrez, Robert G. Gish

Original Articles

Third generation gold nanoplatform optimized for radiation therapy

Rajiv Kumar, Houari Korideck, Wilfred Ngwa, Ross I. Berbeco, G. Mike Makrigiorgos, Srinivas Sridhar

Utilizing signature-score to identify oncogenic pathways of cholangiocarcinoma

Tzu-Hung Hsiao, Hung-I Harry Chen, Jo-Yang Lu, Pei-Ying Lin, Charles Keller, Sarah Comerford, Gail E. Tomlinson, Yidong Chen

Below are the latest Translational Cancer Research articles published online ahead of print publication.

Original Article

A retrospective study of anlotinib in patients with persistent, recurrent or metastatic cervical and endometrial cancer

Lingli Xin, Mei Ye, Yuan Gao, Qi Xiong, Qingxiang Hou

Published online: 26 June 2024

Original Article

Identification and validation of endoplasmic reticulum stress-related genes that enhance immunotherapy in colon cancer

Baolin Wang, Jun Yang, Jiexin Wu, Xiaoming Hu, Jun Zhu, Jiang Fang, Bo Han, Bo Zhou

Published online: 25 June 2024

Review Article

Perioperative systemic therapy in high-risk renal cell carcinoma following nephrectomy: a narrative review

Adam Khorasanchi, Taylor Goodstein, Shawn Dason, Eric A. Singer, Danielle Zimmerman, Yuanquan Yang

Published online: 25 June 2024

Original Article

Integrating artificial intelligence in renal cell carcinoma: evaluating ChatGPT’s performance in educating patients and trainees

J. Patrick Mershon, Tasha Posid, Keyan Salari, Richard S. Matulewicz, Eric A. Singer, Shawn Dason

Published online: 21 May 2024

Review Article

A narrative clinical trials review in the realm of focal therapy for localized prostate cancer

Alon Lazarovich, Vijay Viswanath, Aaron S. Dahmen, Abhinav Sidana

Published online: 16 May 2024

Journal highlight more

Translational Cancer Research is an international, open access, peer-reviewed journal indexed in Scopus and Science Citation Index Expanded (SCIE), focusing on original, science-based researches on clinical, basic and translational aspects. It publishes laboratory studies of novel therapeutic interventions, clinical trials which evaluate new treatment paradigms for cancer, results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients and etc.